Drug · DIN 02562529
ENZEEVU
SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since October 30, 2025.
- Drug Identification Number (DIN)
- 02562529
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Aflibercept S01LA05
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFLIBERCEPT | 2 MG | 0.05 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 30, 2025: NOC 36288New Drug Submission (NDS)
Other DINs named ENZEEVU
- DIN 02562510 · Marketed